Company / Working Capital per Share
Spyre Therapeutics, Inc. Working Capital per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$11.93
FY2025
5-year range
$0.96 / $118.42
FY2021-FY2025
Trend
-22.4%
vs FY2024
Sector context
#38 of 210
Health Care
What the data says
Spyre Therapeutics, Inc.'s working capital per share of $11.93 is higher than 82% of companies in the Health Care sector (FY2025). Working Capital per Share has fluctuated over the past 10 years, ranging from $0.96 in FY2022 to $118.42 in FY2023.
Based on SEC 10-K filings.
11.93 in FY2025 with a 5-year CAGR of +21.1%. Top quartile in the Health Care sector.
Declined from $118.42 to $11.93 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +131.3%
- 5-Year CAGR
- +21.1%
- 10-Year CAGR
- -
Sector benchmark
-91.9% below sector average
Key checks
Key Insights
- In FY2025, working capital per share decreased 22.4% year-over-year.
- Ranks #38 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2023.
- Lowest working capital per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $11.93 | -22.4% |
| FY2024 | $15.38 | -87.0% |
| FY2023 | $118.42 | +12178.1% |
| FY2022 | $0.96 | -41.3% |
| FY2021 | $1.64 | -64.2% |
| FY2020 | $4.58 | +97.1% |
| FY2019 | $2.33 | -41.6% |
| FY2018 | $3.99 | +22.1% |
| FY2017 | $3.26 | -48.8% |
| FY2016 | $6.38 | -89.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026